It has provided evidence that LKB1 deficient cancer cells were sensitive to CDK4/6 inhibitor based on the protein-protein interaction of LKB1/CDK4, supporting the kinase inhibitors function not only as kinase suppressor, but also as signaling regulator based on protein–protein interaction network (Li et al., 2017b). Here, CDK4 is linked to cancer.